The trajectory of Sildenafil presents a complex case for investors in the drug sector. While initially a blockbuster success, creating vast sums, the exclusivity expiration and the subsequent entry of off-brand https://knockoff386696.dm-blog.com/42108596/sildenafil-and-big-pharma-a-speculative-bet